145 related articles for article (PubMed ID: 2827889)
1. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
Kramer SM; Aggarwal BB; Eessalu TE; McCabe SM; Ferraiolo BL; Figari IS; Palladino MA
Cancer Res; 1988 Feb; 48(4):920-5. PubMed ID: 2827889
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
3. Human TNF mutants with selective activity on the p55 receptor.
Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
[TBL] [Abstract][Full Text] [Related]
4. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
[TBL] [Abstract][Full Text] [Related]
5. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha as a proliferative signal for an IL-2-dependent T cell line: strict species specificity of action.
Ranges GE; Bombara MP; Aiyer RA; Rice GG; Palladino MA
J Immunol; 1989 Feb; 142(4):1203-8. PubMed ID: 2536768
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
Haranaka K; Satomi N; Sakurai A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
[TBL] [Abstract][Full Text] [Related]
9. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
Lantz M; Gullberg U; Nilsson E; Olsson I
J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717
[TBL] [Abstract][Full Text] [Related]
10. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion.
Schreiber M; McFadden G
Virology; 1994 Nov; 204(2):692-705. PubMed ID: 7941338
[TBL] [Abstract][Full Text] [Related]
11. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.
Manda T; Nishigaki F; Mori J; Shimomura K
Cancer Res; 1988 Aug; 48(15):4250-5. PubMed ID: 3390820
[TBL] [Abstract][Full Text] [Related]
12. Selective species specificity of tumor necrosis factor for toxicity in the mouse.
Brouckaert P; Libert C; Everaerdt B; Fiers W
Lymphokine Cytokine Res; 1992 Aug; 11(4):193-6. PubMed ID: 1420597
[TBL] [Abstract][Full Text] [Related]
13. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.
Jacobsen SE; Jacobsen FW; Fahlman C; Rusten LS
Stem Cells; 1994; 12 Suppl 1():111-26; discussion 126-8. PubMed ID: 7535144
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis.
Niitsu Y; Watanabe N; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Feb; 48(3):654-7. PubMed ID: 2825981
[TBL] [Abstract][Full Text] [Related]
16. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
Liddil JD; Dorr RT; Scuderi P
Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor.
Nobuhara M; Kanamori T; Ashida Y; Ogino H; Horisawa Y; Nakayama K; Asami T; Iketani M; Noda K; Andoh S
Jpn J Cancer Res; 1987 Feb; 78(2):193-201. PubMed ID: 3030986
[TBL] [Abstract][Full Text] [Related]
18. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor.
Coffman FD; Green LM; Ware CF
Lymphokine Res; 1988; 7(4):371-83. PubMed ID: 2850412
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
20. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.
Watanabe N; Niitsu Y; Yamauchi N; Umeno H; Sone H; Neda H; Urushizaki I
J Biol Response Mod; 1988 Feb; 7(1):24-31. PubMed ID: 2453618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
